MND-231

N/A

Report date: 2022/06/22 16:53:36

Base Information

Drug NameMND-231
Drug Alias NameMND-231
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacementsGastrointestinal microbiome modulators
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMoon (Guangzhou) Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMoon (Guangzhou) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A